Titlebook: Methylotrophy and Methanogenesis; Peter J. Large Book 1983 Springer Science+Business Media New York 1983 ATP.Oxidation.bacteria.biochemist

FLORA

n auch die Software-Unternehmen zum überdenken ihrer Vorgehensweise bei der Software-Entwicklung veranla?t. Dazu kommen die rasanten technologischen Entwicklungssprünge in der Informations- und Kommunikationstechnik, die dazu führen, da? immer schneller neue Softwareprodukte auf dem Markt sind. Beso

擁護者

The Biology and Ecology of Micro-organisms Metabolizing C1 compounds,ds of carbon that are more reduced than carbon dioxide (CO.) and which contain no carbon — carbon bonds, although some contain more than one carbon atom. A list of compounds of this type is given in Table 1.1.

mutineer

Physiology and Biochemistry of Methane-Producing (Methanogenic) Bacteria,s, a nitrogen source and other essential elements, but lacks oxygen, (for example the mud at the bottom of a lake) then an anaerobic microbial population will develop that may contain methanogenic bacteria. Not all such environments are suitable for methanogens. If high concentrations of sulphate or

通便

Oration

Physiology and Biochemistry of Methylotrophic Yeasts,ave not been extensively studied. The reason for considering yeasts in a separate chapter from bacteria is that most of the key reactions of the assimilatory and dissimilatory pathways for C. compounds are different. This is presumably because eukaryotes appeared much later in the history of living

Noisome

Biotechnological Applications of Methanogenic and Methylotrophic Micro-organisms,only to those who wanted to examine the borderline between autotrophy and heterotrophy. At that time also only a few species of methanogenic bacteria had been obtained in pure culture, and our knowledge of the biochemistry of methanogenesis was very slight. One of the reasons for the subsequent trem

LASH

Obsequious

Visual-Field

Peter J. Largesverzeichnis Bezeichnungen . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . IV 1 Einführung . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Anticoagulants

Peter J. Largesverzeichnis Bezeichnungen . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . IV 1 Einführung . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .